A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder	Not yet recruiting	Phase 1	2026-09-10		NCT07813039

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Vertex Pharmaceuticals Incorporated	37

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials